Journal profile · ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal of Contemporary Brachytherapy
ISSN 1689-832X · eISSN 2081-2841 · Termedia Publishing House Ltd. · POLAND
Journal of Contemporary Brachytherapy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.36; fully open access; APC charged, amount not published; median 103 days to acceptance (88 articles, last 24 months); 51 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Contemporary Brachytherapy is published by Termedia Publishing House Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Endometrial and Cervical Cancer Treatments and Prostate Cancer Diagnosis and Treatment, together about 47.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
“Journal of Contemporary Brachytherapy” www.jocb.eu Journal of the Polish Brachytherapy Society and Indian Brachytherapy Society The articles in this journal are published open access (OA) The “Journal of Contemporary Brachytherapy” is an international and multidisciplinary journal that will publish papers of original research as well as reviews of articles. Main subjects of the journal include: clinical brachytherapy, combined modality treatment, advances in radiobiology, hyperthermia and tumour biology, as well as physical aspects relevant to brachytherapy, particularly in the field of imaging, dosimetry and radiation therapy planning. Original contributions will include experimental studies of combined modality treatment, tumor sensitization and normal tissue protection, molecular radiation biology, and clinical investigations of cancer treatment in brachytherapy. Another field of interest will be the educational part of the journal. The “Journal of Contemporary Brachytherapy” publish original peer-reviewed papers, technical advances, reviews of articles, and point/counterpoint of opinions on controversial issues. Original articles regarding any aspect of brachytherapy always are welcome. Educational papers will be prepared and presented by invited authors. Letters to the Editor-in-Chief are highly encouraged. The journal is originally published in the print version. This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access. ISSN: 1689-832X E-ISSN: 2081-2841
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Editor-in-chief Adam ChichełPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy20.2%
- Endometrial and Cervical Cancer TreatmentsMedicine14.5%
- Prostate Cancer Diagnosis and TreatmentMedicine12.9%
- Prostate Cancer Treatment and ResearchMedicine5.3%
- Head and Neck Cancer StudiesMedicine5%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.9%
- Nonmelanoma Skin Cancer StudiesMedicine3.7%
- Colorectal and Anal CarcinomasMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.36LetPub ·
- Impact factor (publisher)
- 1.5Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- SJR 2026-06
- 0.46LetPub ·
- SNIP 2026-06
- 0.7LetPub ·
- h-index
- 17LetPub ·
- h-index
- 38OpenAlex ·
- i10-index
- 362OpenAlex ·
- 2-year mean citedness
- 1.14OpenAlex ·
- Self-citation rate
- 13.3%LetPub ·
- Share of gold OA articles
- 97.47%LetPub ·
Volume
- Articles per year
- 47LetPub ·
Articles by year OpenAlex count · 1,054 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 0 |
| 2025 | 51 | 51 | 32 |
| 2024 | 56 | 56 | 137 |
| 2023 | 62 | 62 | 211 |
| 2022 | 75 | 75 | 353 |
| 2021 | 88 | 88 | 582 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
103 daysMedian, submission to acceptance · P25–P75 75 days – 130 days
- Acceptance to online
- median 36 days (88 articles)
- Submission to online
- median 142 days
- Sample
- 88 articles with submission and acceptance dates (87 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | PLN 1,500 / EUR 350 | Yes | CC BY-NC-SA | |
| OpenAlex | PLN 1,200 / EUR 250 | — | — | |
| LetPub | EUR 250 / PLN 1,200 | Yes | — | |
| Publisher website | EUR 350 / EUR 250 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics
- Conflicts of interest
Conflict of interest disclosure required. Model summary
Sources of funding have to be acknowledged and all authors must disclose any commercial association or other arrangement (financial compensation, potential to profit consultancy, stock ownership, honor, patent - licensing arrangements, etc.) that might pose or imply conflict of interest
Source ↗Publisher website ·- Publication ethics
Declaration of Helsinki endorsed for human research. Model summary
JCB editors endorse the principles embodied in the Declaration of Helsinki
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Termedia Publishing House Ltd.
- Country or region
- POLAND
- Language
- English
- ISSN
- 1689-832X
- Electronic ISSN
- 2081-2841
- Latest issue on the website
- Volume 18 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal of Contemporary Brachytherapy
What CAS zone is Journal of Contemporary Brachytherapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Contemporary Brachytherapy is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Contemporary Brachytherapy?
The latest impact factor listed by LetPub is 1.36; CiteScore 2.4, h-index 38.
How long does peer review take at Journal of Contemporary Brachytherapy?
Based on the dates recorded on 88 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 103 days (interquartile range 75–130 days); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Contemporary Brachytherapy?
According to LetPub and DOAJ records, Journal of Contemporary Brachytherapy is indexed in SCIE, Scopus and DOAJ.
Is Journal of Contemporary Brachytherapy open access, and what is the APC?
Journal of Contemporary Brachytherapy is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .